Etomethazene

Etomethazene (5-methyldesnitroetonitazene, 5-methyl etodesnitazene, Eto) is a benzimidazole derivative with opioid effects which has been sold as a designer drug over the internet since 2022, first being definitively identified in Sweden…

Uses your system voice; voice and rate in settings.

≈ 1 min read

Cite, export and learn8 citation formats · 8 exports · lesson and quiz

Names in other languages

No names in other languages are held for this entry yet.

Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.

Etomethazene (5-methyldesnitroetonitazene, 5-methyl etodesnitazene, Eto) is a benzimidazole derivative with opioid effects which has been sold as a designer drug over the internet since 2022, first being definitively identified in Sweden in January 2023. It is an analogue of etonitazene where the nitro (NO 2 ) group has been replaced by a methyl (CH 3 ) group.

It is less potent than etonitazene itself but still has around twice the potency of fentanyl. Etomethazene has a relatively short duration of action of about 120 min.

Text derived from https://en.wikipedia.org/w/index.php?oldid=1361898123 under CC BY-SA 4.0; modifications have been made.

Provenance

snapshot enwiki-001361898123 · captured 2026-06-30 · ledger · version history

Cite this page as: encyclopegia.org, “Etomethazene”, snapshot enwiki-001361898123. https://encyclopegia.org/a/etomethazene

Sources cited in this revision

4 named source(s) extracted from the cited revision. A source with no author is shown by its publication; nothing is invented.